• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Baxter wins Canadian clearance for infusion system

November 12, 2020 By Sean Whooley

BaxterBaxter (NYSE:BAX) Canada announced today that it received Health Canada authorization for its Novum IQ infusion platform.

Novum IQ received marketing authorization for its large volume pump and syringe infusion pumps, as well as Mississauga, Ontario-based Baxter Canada’s Dose IQ safety software. Baxter expects Novum IQ to be available to Canadian customers in the coming weeks, according to a news release.

“We are excited to introduce Novum IQ, our newest infusion pump platform designed to provide personalized therapy and help prevent harm to patients.” Baxter Canada head of medication delivery Anne-Marie Carli said in the release. “The integrated platform provides for both large volumetric and syringe infusion pumps adding another option for Canadian hospitals to provide high-quality infusion therapy for patients. Novum IQ is a full-suite package offered in both English and French.”

Baxter’s Dose IQ safety software is a web-based, customizable drug library and dose error reduction system which operates to assist clinicians in reducing the occurrence of potential dosing errors.

With Dose IQ as part of the Novum IQ system, Baxter’s newly approved product fully integrates with hospital electronic medical records and can differentiate enteral delivery on the syringe pump through designated screen colors.

Additionally, it offers over-the-air drug library and software updates for all pumps connected to a hospital’s network and provides clear visualizations of infusion data across a hospital system for efficient identification of safety and process issues at every level.

Filed Under: Drug-Device Combinations, Featured, Regulatory/Compliance Tagged With: Baxter, Health Canada

IN CASE YOU MISSED IT

  • Abbott will spend $450M to up FreeStyle Libre production in Ireland
  • Better Therapeutics Q2 beats Street as it prepares to submit diabetes therapy for FDA review
  • Study backs Fluidx embolic device for vessel filling
  • Senseonics stock is up as it sticks by revenue guidance
  • Rapid Dose closes first tranche of $5M financing

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS